Table of Contents
ISRN Hepatology
Volume 2013 (2013), Article ID 959474, 7 pages
http://dx.doi.org/10.1155/2013/959474
Clinical Study

NT-proBNP Changes in Patients with Ascites during Large Volume Paracentesis

1Storr Liver Unit, Westmead Millennium Institute, University of Sydney at Westmead Hospital, Westmead, Sydney, NSW 2145, Australia
2Department of Medical Oncology, Westmead Hospital, Sydney, NSW 2145, Australia
3Department of Medicine, Westmead Hospital, Sydney, NSW 2145, Australia
4Department of Gastroenterology & Hepatology, Westmead Hospital, Sydney, NSW 2145, Australia

Received 3 July 2013; Accepted 21 August 2013

Academic Editors: B. C. Fuchs, A. M. Rijken, and A. K. Singal

Copyright © 2013 Vi Nguyen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Planas, S. Montoliu, B. Ballesté et al., “Natural history of patients hospitalised for management of cirrhotic ascites,” Clinical Gastroenterology and Hepatology, vol. 4, no. 11, pp. 1385–1394, 2006. View at Publisher · View at Google Scholar
  2. L. Tito, P. Ginès, V. Arroyo et al., “Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites,” Gastroenterology, vol. 98, no. 1, pp. 146–151, 1990. View at Google Scholar · View at Scopus
  3. B. A. Runyon, “Care of patients with ascites,” The New England Journal of Medicine, vol. 330, no. 5, pp. 337–342, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Ginès and A. Cárdenas, “The management of ascites and hyponatraemia in cirrhosis,” Seminars in Liver Disease, vol. 28, pp. 43–58, 2008. View at Publisher · View at Google Scholar
  5. F. Salerno, M. Guevara, M. Bernardi et al., “Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis,” Liver International, vol. 30, no. 7, pp. 937–947, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Bernardi, P. Caraceni, R. J. Navickis, and M. M. Wilkes, “Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials,” Hepatology, vol. 55, no. 4, pp. 1172–1181, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Ginés, G. Fernández-Esparrach, A. Monescillo et al., “Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis,” Gastroenterology, vol. 111, no. 4, pp. 1002–1010, 1996. View at Google Scholar · View at Scopus
  8. L. Ruiz-del-Arbol, A. Monescillo, W. Jimenez, A. Garcia-Plaza, V. Arroyo, and J. Rodes, “Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis,” Gastroenterology, vol. 113, no. 2, pp. 579–586, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Saló, A. Ginès, P. Ginès et al., “Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis,” Journal of Hepatology, vol. 27, no. 4, pp. 645–653, 1997. View at Publisher · View at Google Scholar
  10. K. T. Jensen, J. Carstens, P. Ivarsen, and E. B. Pedersen, “A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 57, no. 6, pp. 529–540, 1997. View at Google Scholar · View at Scopus
  11. R. Yildiz, B. Yildirim, M. Karincaoglu, M. Harputluoglu, and F. Hilmioglu, “Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients,” Journal of Gastroenterology and Hepatology, vol. 20, no. 7, pp. 1115–1120, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J. H. Henriksen, J. P. Gøtze, S. Fuglsang, E. Christensen, F. Bendtsen, and S. Møller, “Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease,” Gut, vol. 52, no. 10, pp. 1511–1517, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. K. Kim, W. J. Shin, J. G. Song et al., “Evaluation of intraoperative brain natriuretic peptide as a predictor of 1-year mortality after liver transplantation,” Transplantation Proceedings, vol. 43, no. 5, pp. 1684–1690, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. T. Tamsma, H. J. Keizer, and A. E. Meinders, “Pathogenesis of malignant ascites: Starling's law of capillary hemodynamics revisited,” Annals of Oncology, vol. 12, no. 10, pp. 1353–1357, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. M. C. Vila, R. Solà, L. Molina et al., “Hemodynamic changes in patients with effective hypovolemia after total paracentesis of ascites,” Hepatology, vol. 22, no. 4, p. A163, 1995. View at Google Scholar
  16. P. Ginès, L. Titó, V. Arroyo et al., “Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis,” Gastroenterology, vol. 94, no. 6, pp. 1493–1502, 1988. View at Google Scholar · View at Scopus
  17. B. A. Runyon, “Management of adult patients with ascites due to cirrhosis: an update,” Hepatology, vol. 49, no. 6, pp. 2087–2107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Ginès, P. Angeli, K. Lenz et al., “EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis,” Journal of Hepatology, vol. 53, no. 3, pp. 397–417, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Pozzi, S. Carugo, G. Boari et al., “Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites,” Hepatology, vol. 26, no. 5, pp. 1131–1137, 1997. View at Google Scholar · View at Scopus
  20. S. Møller and J. H. Henriksen, “Cardiovascular complications of cirrhosis,” Gut, vol. 57, no. 2, pp. 268–278, 2008. View at Publisher · View at Google Scholar
  21. J. Pimenta, C. Paulo, A. Gomes, S. Silva, F. Rocha-Gonçalves, and P. Bettencourt, “B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis,” Liver International, vol. 30, no. 7, pp. 1059–1066, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. T. A. Sheer, E. Joo, and B. A. Runyon, “Usefulness of serum N-terminal-proBNP in distinguishing ascites due to cirrhosis from ascites due to heart failure,” Journal of Clinical Gastroenterology, vol. 44, no. 1, pp. e23–e26, 2010. View at Publisher · View at Google Scholar · View at Scopus